ARTICLE | Company News
Rosetta Genomics, U.S. Genomics deal
May 29, 2006 7:00 AM UTC
The companies partnered to discover and develop a microRNA-based test for lung cancer. The deal combines U.S. Genomics’ Trilogy 2020 single molecule detection technology and Direct miRNA assay with Ro...